A RANDOMIZED PHASE 2 TRIAL OF 177LU RADIOLABELED ANTI-PSMA MONOCLONAL ANTIBODY J591 IN PATIENTS WITH HIGH-RISK CASTRATE, BIOCHEMICALLY RELAPSED PROST

$1,201,460FY2009Department of the ArmyDOD

Cornell University, Ithaca NY

Investigators